We are live on ! Find out more
IDXX icon

Idexx Laboratories

761 hedge funds and large institutions have $19.5B invested in Idexx Laboratories in 2019 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 242 increasing their positions, 252 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more first-time investments, than exits

New positions opened: 107 | Existing positions closed: 52

6% more funds holding

Funds holding: 720761 (+41)

0.19% less ownership

Funds ownership: 87.07%86.88% (-0.19%)

4% less repeat investments, than reductions

Existing positions increased: 242 | Existing positions reduced: 252

5% less capital invested

Capital invested by funds: $20.4B → $19.5B (-$923M)

26% less funds holding in top 10

Funds holding in top 10: 1914 (-5)

60% less call options, than puts

Call options by funds: $28.1M | Put options by funds: $71.1M

Holders
761
Holders Change
+41
Holders Change %
+5.69%
% of All Funds
14.95%
Holding in Top 10
14
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-26.32%
% of All Funds
0.27%
New
107
Increased
242
Reduced
252
Closed
52
Calls
$28.1M
Puts
$71.1M
Net Calls
-$43M
Net Calls Change
+$9.96M

IDXX Hedge Fund Activity: Q4 2019 in Review

761 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2019, worth a combined $19.5B — down 4.5% from $20.4B a quarter earlier.

Buyers outnumbered sellers: 107 funds opened new IDXX positions and 52 closed out — a net gain of 55 holders — while 242 added to existing stakes and 252 trimmed.

The largest buyer was BlackRock, adding an estimated $190M. The largest seller was Invesco, cutting an estimated $229M.

  • 761 institutional investors held Idexx Laboratories (IDXX) as of Q4 2019, up from 720 in Q3 2019.
  • Funds reported $19.5B of Idexx Laboratories stock for Q4 2019, down 4.5% quarter-over-quarter.
  • 107 funds opened new Idexx Laboratories positions in Q4 2019 and 52 closed out, a net change of +55 holders.
  • The largest Idexx Laboratories buyer in Q4 2019 was BlackRock, an estimated $190M added.
  • The largest Idexx Laboratories seller in Q4 2019 was Invesco, an estimated $229M sold.

Based on aggregated 13F filings for Q4 2019.